-
Penicillin G Sodium: Applied Assay Workflows
2026-09-25
Build reproducible bacterial growth-inhibition assays with Penicillin G Sodium while accounting for strain susceptibility, solution stability, and controls that distinguish true inhibition from handling artifacts. A renal transporter study offers useful lessons in orthogonal assay design—but not evidence that penicillin G acts on OCT2 or MATE1.
-
DeferoxamineB as a Probe in Cell-Death Assays
2026-09-25
DeferoxamineB offers researchers a way to test how iron availability shapes oxidative stress and regulated cell death. This article connects iron chelation to recent ferroptosis–cuproptosis research and explains how to interpret Deferoxamine as an experimental probe without mistaking it for a component of the cited nanotherapy.
-
HRP Goat Anti-Rabbit IgG in Nerve Repair Research
2026-09-24
Affinity-Purified Goat Anti-Rabbit IgG (H+L) can support rigorous protein detection when researchers investigate lactate-driven macrophage changes after peripheral nerve injury. This article connects recent nerve-regeneration findings to practical assay choices, controls, and interpretation—not just antibody selection.
-
FDA-Approved Library Screening for MERS-CoV Inhibitors
2026-09-24
A screen of 348 FDA-approved compounds identified chloroquine, chlorpromazine, loperamide, and lopinavir as cell-culture inhibitors of MERS-CoV replication, with reported EC50 values in the low-micromolar range. The study established a repurposing lead set and evidence of activity across additional coronaviruses, while leaving efficacy in animals or patients and the compounds’ molecular targets unresolved.
-
Acetylspiramycin: From Ribosome to Translation
2026-09-23
Acetylspiramycin, also known as Spiramycin B, offers translational researchers a useful bridge between ribosomal mechanism, antimicrobial resistance research, assay design, and host-response biology. This article outlines how to position the compound in reproducible susceptibility workflows while avoiding overinterpretation of in vitro activity.
-
Acetylspiramycin: Workflows for Resistance Studies
2026-09-23
Acetylspiramycin (Spiramycin B) gives researchers a defined 16-membered macrolide input for susceptibility testing, ribosome-focused experiments, and host–pathogen models. This guide connects practical solvent handling and broth microdilution with resistance benchmarking, pathway-engineering insights, and immune-modulation controls.
-
Blebbistatin Workflows for Spatial Cell Mechanics
2026-09-22
Use (±)-Blebbistatin to convert migration, adhesion, and morphology imaging into reversible tests of non-muscle myosin II function. A spatially registered workflow, inspired by multimodal cardiac mapping, helps separate local cytoskeletal effects from broad changes in cell health or image appearance.
-
Netarsudil: From ROCK Biology to siRNA Translation
2026-09-21
Netarsudil (AR-13324) offers a useful translational bridge between ROCK biology, trabecular meshwork cell modulation, and predictive siRNA codelivery. This article explains the mechanistic rationale, interprets recent validation data, and outlines a disciplined workflow for moving from cytoskeletal assays to formulation and ocular translation.
-
S63845 MCL1 Inhibitor: Applied Research Guide
2026-09-21
S63845 is a selective MCL1 inhibitor for mapping mitochondrial apoptosis, prioritizing MCL1-dependent hematological models, and testing residual disease after chemotherapy-induced senescence. This guide converts its nanomolar binding profile into practical dosing, validation, troubleshooting, and comparative assay strategies.
-
SB 431542: ALK5 Inhibitor Workflow for Fibrosis
2026-09-20
Use SB 431542 to separate TGF-β receptor signaling from downstream PI3K/AKT effects in fibrosis, cancer, and immune-cell assays. This workflow combines the reference study’s 10 μM A549-cell model with practical controls, phospho-Smad2 readouts, and troubleshooting guidance for reproducible pathway inhibition.
-
RESTRICT-seq maps SCC resistance dependencies
2026-09-19
The preprint introduces RESTRICT-seq, a time-gated CRISPR screening strategy designed to distinguish genetic dependencies that initiate, maintain, or emerge during squamous cell carcinoma resistance. Its identification of epigenetic regulators including KAT6A provides a framework for studying resistance-associated senescence and for prioritizing mechanistically defined follow-up experiments.
-
Sulfisomidine: From Pertussis Data to Assay Design
2026-09-19
Sulfisomidine, also known as sulfamethin, offers a valuable bridge between historical exposure data and modern biochemical assay design. This article interprets the pertussis study as a lesson in matrix control, concentration measurement, and responsible translation across antibacterial and hPON1 research.
-
Epacadostat (INCB024360): IDO1 Assay Guide
2026-09-18
This scenario-driven guide explains how Epacadostat (INCB024360), SKU B6036, can help researchers separate IDO1-mediated immunometabolic effects from nonspecific cytotoxicity in cell and whole-blood assays. It provides practical guidance on solvent controls, dose interpretation, orthogonal readouts, and evidence-based product selection.
-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-09-18
Zhao and colleagues present a standardized whole-blood stimulation protocol that combines innate immune challenges with targeted metabolic interventions. The design preserves the complexity of human blood while enabling reproducible analysis of cytokines and metabolism-dependent immune responses across cohorts.
-
FCCP: From Mitochondrial Stress to Translational Insight
2026-09-17
FCCP converts mitochondrial uncoupling into a controllable experimental lens for studying oxidative phosphorylation, HIF signaling, metabolic phenotypes, and autophagy-oriented discovery workflows.